Herpes Simplex virus type 2 seroprevalence and risk factors among adolescents and youth with HIV-1 in Northern, Tanzania.


Journal

Journal of infection in developing countries
ISSN: 1972-2680
Titre abrégé: J Infect Dev Ctries
Pays: Italy
ID NLM: 101305410

Informations de publication

Date de publication:
30 04 2020
Historique:
received: 25 04 2019
accepted: 14 12 2019
entrez: 8 5 2020
pubmed: 8 5 2020
medline: 20 7 2021
Statut: epublish

Résumé

Herpes Simplex virus type 2 (HSV-2) infection is associated with an increased risk of human immunodeficiency virus type 1 (HIV-1) acquisition and transmission. Individuals co-infected with HIV-1 and HSV-2 may have longer lasting, more frequent and severe outbreaks of herpes symptoms. Previous studies have assessed HSV-2 seroprevalence and associated risk factors in adult populations. However, there is limited data on the HSV-2 seroprevalence among adolescents and youth living with HIV-1. The study aimed to determine the HSV-2 seroprevalence and associated risk factors among adolescents and youth living with HIV-1 at referral hospital setting in Northern Tanzania. A cross-sectional survey was conducted between February and July 2017 among HIV-1-infected individuals aged 10-24 years attending the Child -Centred Family Care Clinic at Kilimanjaro Christian Medical Centre. Blood specimens from 180 individuals were collected for ELISA-based detection of HSV-2 antibodies. Associations between risk factors and HSV-2 seroprevalence were analysed by univariate and multivariate logistic regression models. The overall HSV-2 seroprevalence was 18% (32/180). A significant HSV-2 seroprevalence was noted among adolescents and youth, who reported having had sexual intercourse than those who never had sexual intercourse (28.9% vs 13.3%, p = 0.02). Youths aged 20-24 had six folds higher risk of HSV-2 seroprevalence compared to those aged 10-14 years (AOR = 5.97 95% CI 1.31 - 27.19, p = 0.02). Our study found that HSV-2 seroprevalence increased by age among adolescents and youth living with HIV-1. Age-specific approaches might play an important role in interventions targeting HSV-2 infection.

Identifiants

pubmed: 32379718
doi: 10.3855/jidc.11599
doi:

Substances chimiques

Antibodies, Viral 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

398-403

Informations de copyright

Copyright (c) 2020 Rashid Madebe, Ireen Kiwelu, Arnold Ndaro, Filbert Francis, Vito Baraka, Zahra Theilgaard, Terese Katzenstein.

Déclaration de conflit d'intérêts

No Conflict of Interest is declared

Auteurs

Rashid Madebe (R)

Kilimanjaro Christian Medical University College, Moshi, Tanzania. ramadebe11@gmail.com.

Ireen Kiwelu (I)

Kilimanjaro Christian Medical University College, Moshi, Tanzania. i.kiwelu@kcri.ac.tz.

Arnold Ndaro (A)

Kilimanjaro Christian Medical Centre, Moshi, Tanzania. a.ndaro@kcri.ac.tz.

Filbert Francis (F)

National Institute for Medical Research, Tanga Centre, Tanzania. ffrancis8@gmail.com.

Vito Baraka (V)

National Institute for Medical Research, Tanga Centre, Tanzania. vitobaraka@gmail.com.

Zahra Theilgaard (Z)

Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. zahraptheilgaard@gmail.com.

Terese Katzenstein (T)

Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark. terese.katzenstein@regionh.dk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH